BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24531534)

  • 1. Cytotoxicity of cyclometalated platinum complexes based on tridentate NCN and CNN-coordinating ligands: remarkable coordination dependence.
    Vezzu DA; Lu Q; Chen YH; Huo S
    J Inorg Biochem; 2014 May; 134():49-56. PubMed ID: 24531534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appended Aromatic Moieties Determine the Cytotoxicity of Neutral Cyclometalated Platinum(II) Complexes Derived from 2-(2-Pyridyl)benzimidazole.
    Vaquero M; Busto N; Fernández-Pampín N; Espino G; García B
    Inorg Chem; 2020 Apr; 59(7):4961-4971. PubMed ID: 32182052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination environment dependence of anticancer activity in cyclometalated bismuth(III) complexes with C,O-chelating ligands.
    Lei J; Liu Y; Yin M; Li S; Wang Z; Chen Y
    J Inorg Biochem; 2024 Jul; 256():112571. PubMed ID: 38669912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium(II) saccharinate complexes with bis(2-pyridylmethyl)amine induce cell death by apoptosis in human breast cancer cells in vitro.
    Ari F; Ulukaya E; Sarimahmut M; Yilmaz VT
    Bioorg Med Chem; 2013 Jun; 21(11):3016-21. PubMed ID: 23601820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
    Zhou Z; Chen F; Xu G; Gou S
    Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
    Sun Y; Wei H; Zhang Q; Zhao X
    Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
    Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
    J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
    Göschl S; Varbanov HP; Theiner S; Jakupec MA; Galanski MS; Keppler BK
    J Inorg Biochem; 2016 Jul; 160():264-74. PubMed ID: 27055943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy.
    Yusoh NA; Ahmad H; Gill MR
    ChemMedChem; 2020 Nov; 15(22):2121-2135. PubMed ID: 32812709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
    Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
    Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine.
    Mojaddami A; Karimi A; Mahdavinia M; Fereidoonnezhad M
    Biometals; 2022 Jun; 35(3):617-627. PubMed ID: 35445906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
    Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
    Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.